Lipigon Pharmaceuticals AB's total assets for Q3 2025 were kr18.08M, a decrease of -31.94% from the previous quarter. SE:LPGO total liabilities were kr2.99M for the fiscal quarter, a -27.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.